These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 9813988)

  • 1. Typhoid fevers: treatment with lomefloxacin.
    Hafiz S; Habib F; Ahmad N; Haq I; Husain R
    J Pak Med Assoc; 1998 Jun; 48(6):168-70. PubMed ID: 9813988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
    Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
    BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of ofloxacin against 210 clinical isolates of typhoid salmonellae.
    Hannan A
    Infection; 1986; 14 Suppl 4():S243-4. PubMed ID: 3102385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae.
    Crump JA; Barrett TJ; Nelson JT; Angulo FJ
    Clin Infect Dis; 2003 Jul; 37(1):75-81. PubMed ID: 12830411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
    Butt T; Khan MY; Ahmad RN; Salman M; Afzal RK
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):31-4. PubMed ID: 16441985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing trends in drug resistance among typhoid salmonellae in Rawalpindi, Pakistan.
    Butt T; Ahmad RN; Salman M; Kazmi SY
    East Mediterr Health J; 2005; 11(5-6):1038-44. PubMed ID: 16761675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A three-year review of antimicrobial resistance of Salmonella enterica serovars Typhi and Paratyphi A in Pakistan.
    Qamar FN; Azmatullah A; Kazi AM; Khan E; Zaidi AK
    J Infect Dev Ctries; 2014 Aug; 8(8):981-6. PubMed ID: 25116662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enteric fever in Karachi: current antibiotic susceptibility of Salmonellae isolates.
    Abdullah FE; Haider F; Fatima K; Irfan S; Iqbal MS
    J Coll Physicians Surg Pak; 2012 Mar; 22(3):147-50. PubMed ID: 22414353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance in typhoidal salmonellae.
    Harish BN; Menezes GA
    Indian J Med Microbiol; 2011; 29(3):223-9. PubMed ID: 21860101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in minimum inhibitory concentration to quinolones and ceftriaxone in salmonellae causing enteric fever.
    Sekar U; Srikanth P; Kindo AJ; Babu VP; Ramasubramanian V
    J Commun Dis; 2003 Sep; 35(3):162-9. PubMed ID: 15796408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi.
    Jain S; Das Chugh T
    J Infect Dev Ctries; 2013 Nov; 7(11):788-95. PubMed ID: 24240035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of typhoidal Salmonellae against newer antimicrobial agents: a search for alternate treatment options.
    Qaiser S; Irfan S; Khan E; Ahsan T; Zafar A
    J Pak Med Assoc; 2011 May; 61(5):462-5. PubMed ID: 22204180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An increase in enteric fever cases due to Salmonella Paratyphi A in & around Chandigarh.
    Gupta V; Kaur J; Chander J
    Indian J Med Res; 2009 Jan; 129(1):95-8. PubMed ID: 19287065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical course of cases of typhoid and paratyphoid A and B fevers in relation to the sensitivity of the causative agent to chloramphenicol].
    Palomino C; Aguad L; Rodríguez M; Cofre G; Villanueva J
    Rev Med Chil; 1986 Oct; 114(10):919-27. PubMed ID: 3107100
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimicrobial susceptibility patterns of Salmonella typhi and Salmonella paratyphi A in a tertiary care hospital.
    Raza S; Tamrakar R; Bhatt CP; Joshi SK
    J Nepal Health Res Counc; 2012 Sep; 10(22):214-7. PubMed ID: 23281454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmid-mediated quinolone resistance in typhoidal Salmonellae: a preliminary report from South India.
    Geetha VK; Yugendran T; Srinivasan R; Harish BN
    Indian J Med Microbiol; 2014; 32(1):31-4. PubMed ID: 24399384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolones in Salmonella typhi infection.
    DuPont HL
    Drugs; 1993; 45 Suppl 3():119-24. PubMed ID: 7689442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of enteric fever with pefloxacin for 7 days versus 5 days: a randomized clinical trial.
    Unal S; Hayran M; Tuncer S; Gür D; Uzun O; Akova M; Akalin HE
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2898-900. PubMed ID: 9124864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Two cases of typhoid fever with reduced susceptibility to fluoroquinolones].
    Adachi T; Masuda G; Imamura A; Ajisawa A; Negishi M; Takayama N; Takinaga K; Takano S
    Kansenshogaku Zasshi; 2001 Jan; 75(1):48-52. PubMed ID: 11218386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An outbreak of multiresistant Salmonella typhi in South Africa.
    Coovadia YM; Gathiram V; Bhamjee A; Garratt RM; Mlisana K; Pillay N; Madlalose T; Short M
    Q J Med; 1992 Feb; 82(298):91-100. PubMed ID: 1620817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.